Among MAPKs, p38 phosphorylation levels correlated with clinical parameters of periodontal disease progression, and oral administration of a selective p38α inhibitor protected against alveolar bone loss in LPS-induced periodontitis in rats (43, 44). This evidence concerns the gene MAPK14 and periodontitis.